Skip to main content

Advertisement

SpringerLink
Log in

Absence of the BRCA1 del (exons 9–12) mutation in breast/ovarian cancer families outside of Mexican Hispanics

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60(5):1013–1020

    PubMed  CAS  Google Scholar 

  2. Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J, McGuire C, Neuhausen S (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14(7):1666–1671. doi:10.1158/1055-9965.EPI-05-0072

    Article  PubMed  CAS  Google Scholar 

  3. Jara L, Ampuero S, Santibanez E, Seccia L, Rodríguez J, Bustamante M, Martínez V, Catenaccio A, Lay-Son G, Blanco R, Reyes JM (2006) BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 166(1):36–45. doi:10.1016/j.cancergencyto.2005.08.019

    Article  PubMed  CAS  Google Scholar 

  4. Torres D, Rashid MU, Gil F, Umana A, Ramelli G, Robledo JF, Tawil M, Torregrosa L, Briceno I, Hamann U (2007) High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. Breast Cancer Res Treat 103(2):225–232. doi:10.1007/s10549-006-9370-1

    Article  PubMed  CAS  Google Scholar 

  5. Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119(12):2832–2839. doi:10.1002/ijc.22269

    Article  PubMed  CAS  Google Scholar 

  6. Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20(6):413–424. doi:10.1002/humu.10154

    Article  PubMed  CAS  Google Scholar 

  7. Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, Lerman C (1997) Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 32(1–2):51–62. doi:10.1016/S0738-3991(97)00064-5

    Article  PubMed  CAS  Google Scholar 

  8. Hughes C, Lerman C, Lustbader E (1996) Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 40(1):25–35. doi:10.1007/BF01806000

    Article  PubMed  CAS  Google Scholar 

  9. Croyle RT, Lerman C (1999) Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 25:59–66

    PubMed  Google Scholar 

  10. Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frénay M, Gilbert B, Maugard C, Bignon YJ, Chevrier A, Rossi A, Fricker JP, Nguyen TD, Demange L, Aurias A, Bensimon A, Stoppa-Lyonnet D (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21(44):6841–6847. doi:10.1038/sj.onc.1205685

    Article  PubMed  CAS  Google Scholar 

  11. Casilli F, Tournier I, Sinilnikova OM, Coulet F, Soubrier F, Houdayer C, Hardouin A, Berthet P, Sobol H, Bourdon V, Muller D, Fricker JP, Capoulade-Metay C, Chompret A, Nogues C, Mazoyer S, Chappuis P, Maillet P, Philippe C, Lortholary A, Gesta P, Bézieau S, Toulas C, Gladieff L, Maugard CM, Provencher DM, Dugast C, Delvincourt C, Nguyen TD, Faivre L, Bonadona V, Frébourg T, Lidereau R, Stoppa-Lyonnet D, Tosi M (2006) The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 43(9):e49. doi:10.1136/jmg.2005.040212

    Article  PubMed  CAS  Google Scholar 

  12. Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL (2008) The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res 68(17):7006–7014. doi:10.1158/0008-5472.CAN-08-0599

    Article  PubMed  Google Scholar 

  13. Ferla R, Calo V, Cascio S, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V, Russo A (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl 6):vi93–vi98. doi:10.1093/annonc/mdm234

    Article  PubMed  Google Scholar 

  14. Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, Ricker CN, Lowstuter KJ, Blazer KR, Tomlinson G, Scholl T (2007) Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 16(8):1615–1620. doi:10.1158/1055-9965.EPI-07-0198

    Article  PubMed  CAS  Google Scholar 

  15. Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ (1997) German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene. Genes Chromosomes Cancer 18(2):126–132. doi:10.1002/(SICI)1098-2264(199702)18:2<126:AID-GCC7>3.0.CO;2-4

    Article  PubMed  CAS  Google Scholar 

  16. Hamann U, Haner M, Stosiek U, Bastert G, Scott RJ (1997) Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families. J Med Genet 34(11):884–888. doi:10.1136/jmg.34.11.884

    Article  PubMed  CAS  Google Scholar 

  17. Hamann U, Liu X, Lange S, Ulmer HU, Benner A, Scott RJ (2002) Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany. J Med Genet 39(3):E12. doi:10.1136/jmg.39.3.e12

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are indebted to all women who had participated in this study. We gratefully acknowledge support by the physicians in Pakistan and Germany. This work was financed by the Deutsches Krebsforschungszentrum, Heidelberg and in part by a grant of Dr. Weitzel from the California Breast Cancer Research Program.

Author information

Authors and Affiliations

  1. Deutsches Krebsforschungszentrum, Research Group Molecular Genetics of Breast Cancer, Im Neuenheimer Feld 580, 69120, Heidelberg, Germany

    Muhammad U. Rashid, Antje Seidel-Renkert & Ute Hamann

  2. Instituto de Genetica Humana, Pontificia Universidad Javeriana, Universidad de la Sabana, Bogota, Colombia

    Diana Torres & Ignacio Briceno

  3. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

    Muhammad U. Rashid

  4. Department of Clinical Cancer Genetics, City of Hope, Duarte, CA, USA

    Jeffrey N. Weitzel

Authors
  1. Diana Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Muhammad U. Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antje Seidel-Renkert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeffrey N. Weitzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ignacio Briceno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ute Hamann
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Colombian Breast Cancer Study Group (COLBCS)

Corresponding author

Correspondence to Ute Hamann.

Additional information

Diana Torres and Muhammad U. Rashid contributed equally to this work.

Colombian Breast Cancer Study Group (COLBCS): Angela Beltran, Viviana Ariza, Angela Umana, MSc., Fabian Gil (Pontificia Universidad Javeriana, Bogota); clinicians and hospitals: Jose Fernando Robledo, M.D., Jose Caicedo, M.D., Elías Quintero, M.D., Alejandro Orozco, M.D. (Country Clinic, Bogota); Mauricio Tawil, M.D., Lilian Torregrosa, M.D. (Pontificia Universidad Javeriana, Bogota).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torres, D., Rashid, M.U., Colombian Breast Cancer Study Group (COLBCS). et al. Absence of the BRCA1 del (exons 9–12) mutation in breast/ovarian cancer families outside of Mexican Hispanics. Breast Cancer Res Treat 117, 679–681 (2009). https://doi.org/10.1007/s10549-009-0383-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0383-4

Keywords

Search

Navigation